Shanghai Fangdian Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shanghai Fangdian Biotechnology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include FD FONDIN and EASYBOOSTER.

3rd Floor, Building 3, No. 18, Lane 1588,

Dingwu Road, Lingang New Area 201304 China (Shanghai) Pilot Free Trade Zone

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Shanghai Fangdian Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Shanghai Fangdian Biotechnology Co., Ltd. have?

Shanghai Fangdian Biotechnology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Shanghai Fangdian Biotechnology Co., Ltd. file in?

Shanghai Fangdian Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Shanghai Fangdian Biotechnology Co., Ltd.'s most well-known trademarks?

Shanghai Fangdian Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as FD FONDIN and EASYBOOSTER. These are among 2 currently registered trademarks in the portfolio.

What is Shanghai Fangdian Biotechnology Co., Ltd.'s trademark registration success rate?

Shanghai Fangdian Biotechnology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.